<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Pfizer]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Pfizer on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=53607"/>
<item>
<title><![CDATA[SAC's Martoma says U.S. impedes defense in fraud case]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/21/sac-martoma-says-us-impedes-defense-in-fraud-case/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/21/sac-martoma-says-us-impedes-defense-in-fraud-case/</guid>
<pubDate><![CDATA[Tue, 21 May 2013 11:20:07 EDT]]></pubDate>
<description><![CDATA[Former SAC Capital Advisors portfolio manager Mathew Martoma said the government is impeding his ability to defend against criminal insider trading charges by trying to link him to an alleged long-running conspiracy for which it has only "vague" details.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/feeds/Reuters/2013/05/21/2013-05-21T152007Z_1_CBRE94K16LO00_3_USA-CRIME-INSIDERTRADING.JPG</media:thumbnail>
</item>
<item>
<title><![CDATA[Elan Sets Out Deal Plans]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/20/elan-sets-out-deal-plans/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/20/elan-sets-out-deal-plans/</guid>
<pubDate><![CDATA[Mon, 20 May 2013 06:15:02 EDT]]></pubDate>
<description><![CDATA[Elan Corp. PLC (DRX.DB) Monday shed further light on plans to rebuild its business and secure its long-term future, three months after selling off its only drug in production in a $3.25 billion deal.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Novartis Considers Possible Bid for Actavis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/15/novartis-considers-possible-bid-for-actavis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/15/novartis-considers-possible-bid-for-actavis/</guid>
<pubDate><![CDATA[Wed, 15 May 2013 18:45:04 EDT]]></pubDate>
<description><![CDATA[A heated takeover battle has erupted around generic-drug company Actavis Inc. (ACT) as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pair of Studies Show Power of Immune System to Fight Cancer]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/15/pair-studies-show-power-immune-system-to-fight-cancer/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/15/pair-studies-show-power-immune-system-to-fight-cancer/</guid>
<pubDate><![CDATA[Wed, 15 May 2013 18:15:27 EDT]]></pubDate>
<description><![CDATA[Positive results from two early-stage studies of drugs from Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY) provided fresh evidence that the power of the immune system is emerging as a promising new weapon against cancer.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/pfizer-has-second-recall-thyroid-disorder-drug-levoxyl/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/pfizer-has-second-recall-thyroid-disorder-drug-levoxyl/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 16:52:13 EDT]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) issued its second recall of thyroid-disease treatment Levoxyl in recent weeks, this time because some tablets didn't meet potency standards.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Analysis: Drugmakers face more scrutiny of discordant U.S. prices]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/analysis-drugmakers-face-more-scrutiny-discordant-us-prices/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/analysis-drugmakers-face-more-scrutiny-discordant-us-prices/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 11:20:07 EDT]]></pubDate>
<description><![CDATA[The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pain Therapeutics: Pfizer Reassessing Continued Remoxy Partnership]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/pain-therapeutics-pfizer-reassessing-continued-remoxy-partnership/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/pain-therapeutics-pfizer-reassessing-continued-remoxy-partnership/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 07:05:47 EDT]]></pubDate>
<description><![CDATA[Pain Therapeutics Inc. (PTIE) said Pfizer Inc. (PFE) is evaluating its continued participation in the development of the pain-medicine candidate Remoxy and doesn't know when a final decision will be made.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Americans Spending Less on Medicines]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/08/us-spending-on-medicines-fell-for-first-time-in-2012/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/08/us-spending-on-medicines-fell-for-first-time-in-2012/</guid>
<pubDate><![CDATA[Wed, 08 May 2013 23:59:59 EDT]]></pubDate>
<description><![CDATA[Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/medicine_pills_health_care.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[U.S. Offshore Earnings Hit $1.9 Trillion, Study Says]]></title>
<link><![CDATA[http://www.foxbusiness.com/investing/2013/05/08/study-us-companies-overseas-earnings-hit-1-trillion/?]]></link>
<guid>http://www.foxbusiness.com/investing/2013/05/08/study-us-companies-overseas-earnings-hit-1-trillion/</guid>
<pubDate><![CDATA[Wed, 08 May 2013 15:38:27 EDT]]></pubDate>
<description><![CDATA[Large U.S. companies boosted their offshore earnings by 15% last year to a record $1.9 trillion, avoiding hefty tax bills by keeping the profits abroad, according to a new report.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/news/US-currency.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[WebMD First-Quarter Loss Narrows; Chief Executive to Step Down]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/07/webmd-first-quarter-loss-narrows-chief-executive-to-step-down/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/07/webmd-first-quarter-loss-narrows-chief-executive-to-step-down/</guid>
<pubDate><![CDATA[Tue, 07 May 2013 17:00:00 EDT]]></pubDate>
<description><![CDATA[WebMD Health Corp.'s (WBMD) first-quarter loss narrowed as the health-information provider posted revenue growth and lower expenses and also said its chief executive is stepping down.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[U.S. Stocks Hit New Highs as Global Rally Continues]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/07/us-stocks-hit-new-highs-as-global-rally-continues/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/07/us-stocks-hit-new-highs-as-global-rally-continues/</guid>
<pubDate><![CDATA[Tue, 07 May 2013 11:11:18 EDT]]></pubDate>
<description><![CDATA[The Dow industrials rose back up above 15000 and the Standard & Poor's 500-stock index pushed deeper into record territory, following strong economic data in Germany, a surprise rate cut in Australia and a jump in Japanese stocks.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer to Sell Viagra Online: Will Other Pharma Companies Follow Suit?]]></title>
<link><![CDATA[http://www.foxbusiness.com/personal-finance/2013/05/06/pfizer-to-sell-viagra-online-will-other-pharma-companies-follow-suit/?]]></link>
<guid>http://www.foxbusiness.com/personal-finance/2013/05/06/pfizer-to-sell-viagra-online-will-other-pharma-companies-follow-suit/</guid>
<pubDate><![CDATA[Mon, 06 May 2013 14:27:32 EDT]]></pubDate>
<description><![CDATA[Bashful men looking to get their hands on Viagra can now fill their prescriptions in the privacy of their own homes.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fn-latino/health/Viagra.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-down-on-loss-singulair-exclusivity/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 15:58:38 EDT]]></pubDate>
<description><![CDATA[Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co. (MRK) becoming the second company after Pfizer Inc. (PFE) to report disappointing sales for the first quarter and lower its full-year outlook.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[ING U.S. Plans 2nd-Largest U.S. Debut in 2013]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/ing-us-plans-2nd-largest-us-debut-in-2013/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/ing-us-plans-2nd-largest-us-debut-in-2013/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 12:25:03 EDT]]></pubDate>
<description><![CDATA[The market for initial public offerings has been hot this year, but it faces a test with ING U.S.'s $1.4 billion debut, slated to be the second-biggest U.S. IPO this year.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Earnings Trigger Volume Spike in Pharma ETF]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/earnings-trigger-volume-spike-in-pharma-etf/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/earnings-trigger-volume-spike-in-pharma-etf/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 10:41:27 EDT]]></pubDate>
<description><![CDATA[On Tuesday, it was Pfizer (NYSE:PFE).]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck Net Dips 8%; Approves $15 Billion Stock Buyback]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-net-dips-8-approves-15-billion-stock-buyback/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-net-dips-8-approves-15-billion-stock-buyback/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 08:25:03 EDT]]></pubDate>
<description><![CDATA[Merck & Co.'s (MRK) first-quarter earnings fell 8.3% as pharmaceutical sales declined amid generic competition for Singulair, which lost U.S. patent protection last year.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Merck 1st-Quarter Profit Off 8.3% Amid Loss of Singular Exclusivity]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-off-83-amid-loss-singular-exclusivity/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/01/merck-1st-quarter-profit-off-83-amid-loss-singular-exclusivity/</guid>
<pubDate><![CDATA[Wed, 01 May 2013 07:31:37 EDT]]></pubDate>
<description><![CDATA[Merck & Co.'s (MRK) first-quarter earnings fell 8.3% as pharmaceutical sales declined amid generic competition for Singulair, which lost U.S. patent protection last year.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Expert network firm hires Texas-based SEC lawyer]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/expert-network-firm-hires-texas-based-sec-lawyer/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/expert-network-firm-hires-texas-based-sec-lawyer/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 18:49:45 EDT]]></pubDate>
<description><![CDATA[Gerson Lehrman Group, the country's largest expert network firm, has hired a Securities and Exchange Commission enforcement attorney to serve as its chief compliance counsel, the company confirmed on Tuesday.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[U.S. Stocks End April at New Highs as Apple Fuels Tech Gains]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/us-stocks-end-april-at-new-highs-as-apple-fuels-tech-gains/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/us-stocks-end-april-at-new-highs-as-apple-fuels-tech-gains/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 16:37:20 EDT]]></pubDate>
<description><![CDATA[U.S. stocks overcame a morning slide to help the Standard & Poor's 500-stock index inch to a new record high, as Apple Inc. led a rally in technology stocks.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer 1st-Quarter Profit, Sales Miss Estimates as Lipitor Pressure Continues]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/30/pfizer-1st-quarter-profit-sales-miss-estimates-as-lipitor-pressure-continues/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/30/pfizer-1st-quarter-profit-sales-miss-estimates-as-lipitor-pressure-continues/</guid>
<pubDate><![CDATA[Tue, 30 Apr 2013 16:11:56 EDT]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) reported a worse-than-expected 9% revenue decline for the first quarter and lowered its full-year outlook as the drug maker continues to struggle to replace billions of dollars in lost Lipitor sales.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
